Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether taking interleukin-2 (IL-2) and other anti-HIV
drugs affects the course of HIV disease in patients with primary HIV infection (the time
period that immediately follows infection with HIV).
After primary HIV infection, the actual infection is spread through an increasing amount of
HIV virus in the body. Studies have shown that, by taking a combination of anti-HIV drugs, it
is possible to reduce the amount of HIV in the body to almost undetectable levels. This study
will find out if starting anti-HIV drugs during primary infection will interrupt or reduce
the spread of HIV in patients' bodies.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)